What is the CANF stock price prediction for next 2 weeks?

According to our price prediction algorithm,Can-Fite BioPharma Ltd. (CANF) price will be around $0.21 in the next 2 weeks. This means it will decrease by -16.58072193573979 from the last closing price. This prediction may vary from other time period filters for CANF stock.

What can be the highest Possible price of CANF stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, CANF can achieve the highest price of $0.24 which is -5.51757755976802 lower than last closing price. This prediction may vary from other time period filters for CANF stock.

What can be the lowest Possible price of CANF stock in next 2 weeks?

As per the forecast and algorithmic analysis, CANF stock price can be as low as $0.18 which is -27.823947878458828 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for CANF stock.

Will CANF stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that CANF stock will lose-16.58072193573979 in the next 2 weeks. This prediction may vary from other time period filters for CANF stock.

What is CANF stock last closing price?

Last closing price of CANF stock was $0.25.

What is CANF stock price prediction?

CANF stock price prediction means predicting the future closing prices of CANF stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of CANF stock in a certain time period.

How we predict CANF stock future prices?

If you are searching for CANF stock forecast, analysis or price prediction, then you might be wondering what Can-Fite BioPharma Ltd. (CANF) will do in the future. Our CANF price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This CANF price prediction will likely answer most of your questions.

How frequent we update CANF stock predictions?

We are updating the forecasts for the CANF stock on daily basis.

Is using ML forecasting for CANF stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for CANF stock same for all the time periods?

No, the prediction for CANF stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Can-Fite BioPharma Ltd. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$0.25-22.91%Since 2 Weeks

Predicted Price$0.21-16.58%For 2 Weeks

Upper Predicted Price$0.24-5.52%For 2 Weeks

Lower Predicted Price$0.18-27.82%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of CANF will decline by -16.58% over the next 2 Weeks and hit $0.21 by Friday, January 2, 2026. In that time frame, CANF's share price is expected to range between $0.18 and $0.24.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jan 2, 2026	0.18	0.21	0.24
Jan 1, 2026	0.19	0.22	0.24
Dec 31, 2025	0.19	0.22	0.25
Dec 30, 2025	0.21	0.24	0.27
Dec 29, 2025	0.21	0.24	0.26
Dec 26, 2025	0.21	0.23	0.26
Dec 25, 2025	0.21	0.24	0.27
Dec 24, 2025	0.22	0.25	0.27
Dec 23, 2025	0.23	0.26	0.29
Dec 22, 2025	0.23	0.26	0.29

CANF shares fell -2.94% in Monday, December 22, 2025's trading session, dropping from a previous close of $0.25 to move at $0.24. The stock demonstrated notable intraday movement (see CANF's key stats for a full breakdown), fluctuating between $0.24 and $0.26, a +6.83% trading range. While recent weeks have seen some volatility, CANF has managed to secure a -21.82% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 729.71K shares changing hands, 114.23K more than the previous session. This amounted to $178.56K in total market activity.

Will CANF Continue Its Downward Trend?

According to analyst ratings and projections for CANF, Can-Fite BioPharma Ltd. shares are anticipated to decrease by -2.21%, potentially reaching $0.24 per share by January 2, 2026. Short-term technical indicators currently suggest a neutral sentiment for CANF. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 7 positive trading days within the past 30 sessions. Based on the CANF stock forecast, now is not the best time to buy CANF stock because its current trading price is +16.36% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CANF covering social and institutional perspectives.

CANF Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into CANF's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 27.88% to 30.20%) suggest the stock is experiencing strong bearish momentum. The 50-day RSI, at 32.32%, hints at potential weakness developing in the medium term. Meanwhile, the 100-day RSI, at 38.52%, signals a bearish bias in the long-term trend. Insights into CANF's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Can-Fite BioPharma Short-Term Forecasts

CANF Forecast For Next 5 Days

Our algorithm anticipates Can-Fite BioPharma (CANF) stock could hit $0.23 by Dec 29, 2025. This represents a -5.52% fall from today's price, following a -12.80% change over the past five days.

CANF Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Can-Fite BioPharma Ltd. (CANF) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.21, which would mean a -14.18% decrease from the current price of $0.24. Projections for this period range from a high of $0.27 to a low of $0.14.

CANF Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Can-Fite BioPharma's price over the next three months point to a rise. CANF stock is expected to peak at $0.87 on Dec 22, 2025 before potentially dipping to $0.32 on Feb 27, 2026. On average, CANF is likely to trade around $0.53 in the coming 90 days.

Can-Fite BioPharma Stock Forecast 2025

Based on our predictive models, Can-Fite BioPharma (CANF) is expected to trade between $0.64 and $0.87 throughout 2025. This would result in an average price of $0.76, potentially offering investors a +210.58% return from current levels.

Can-Fite BioPharma Ltd. Monthly Forecast 2025–2026

December 2025

According to our latest forecast models, Can-Fite BioPharma Ltd. (CANF) is positioned to show a strong performance in December 2025. The price is predicted to move between $0.64 and $0.87, settling at an average of $0.76. This could translate to a +210.58% gain.

January 2026

Based on current market signals, Can-Fite BioPharma Ltd. is projected to trend january 2026. We forecast a trading range from $0.36 to $0.78, with a likely average price of $0.61. Investors could expect a potential return of +149.28%.

February 2026

Our predictive algorithms indicate Can-Fite BioPharma Ltd. stock may see a shift in February 2026. The expected range spans $0.32–$0.52, with an average target of $0.43. This represents a positive outlook and a possible gain of +75.73%.

March 2026

Analyzing established trends, Can-Fite BioPharma Ltd. looks set to move in March 2026. Projections place the stock between $0.25 and $0.52, averaging around $0.43. This suggests a +75.73% gain from current levels.

April 2026

Market indicators suggest Can-Fite BioPharma Ltd. could experience notable changes during April 2026. Prices could fluctuate within $0.07 to $0.40, with a midpoint forecast of $0.26. The stock might deliver a +6.25% gain.

May 2026

Forecasting for May 2026, models estimate that Can-Fite BioPharma Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.24, averaging $0.24. This signals a cautious trajectory with potential returns around -1.92%.

June 2026

According to our latest forecast models, Can-Fite BioPharma Ltd. (CANF) is positioned to show a strong performance in June 2026. The price is predicted to move between $0.00 and $0.21, settling at an average of $0.24. This could translate to a -1.92% loss.

July 2026

Based on current market signals, Can-Fite BioPharma Ltd. is projected to trend july 2026. We forecast a trading range from $0.00 to $0.08, with a likely average price of $0.21. Investors could expect a potential return of -14.18%.

August 2026

Our predictive algorithms indicate Can-Fite BioPharma Ltd. stock may see a shift in August 2026. The expected range spans $0.00–$0.00, with an average target of $0.16. This represents a cautious outlook and a possible loss of -34.61%.

September 2026

Analyzing established trends, Can-Fite BioPharma Ltd. looks set to move in September 2026. Projections place the stock between $0.00 and $0.00, averaging around $0.10. This suggests a -59.13% loss from current levels.

October 2026

Market indicators suggest Can-Fite BioPharma Ltd. could experience notable changes during October 2026. Prices could fluctuate within $0.00 to $0.00, with a midpoint forecast of $0.09. The stock might deliver a -63.22% loss.

November 2026

Forecasting for November 2026, models estimate that Can-Fite BioPharma Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $0.08. This signals a cautious trajectory with potential returns around -67.31%.

December 2026

According to our latest forecast models, Can-Fite BioPharma Ltd. (CANF) is positioned to show a strong performance in December 2026. The price is predicted to move between $0.00 and $0.00, settling at an average of $0.07. This could translate to a -71.39% loss.

CANF's history of dividends and stock splits also plays a role in long-term investor confidence.